FDA Inspection
Sun Pharmaceutical Medicare LimitedSun Pharmaceutical Medicare Limited – FDA Inspection, Feb 27, 2024
Record Details
This FDA Inspection record concerns Sun Pharmaceutical Medicare Limited, with an inspection on February 27, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d438054a-b0f3-4e2d-a220-67bd22a3fc9b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1231121
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sun Pharmaceutical Medicare Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Office of Inspections and Investigations | |
| July 13, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | Not classified | Office of Inspections and Investigations | |
| August 11, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Sun Pharmaceutical Medicare Limited
- FDA Inspection 1288660 - 2025-09-19
- FDA Inspection 1210949 - 2023-07-13
- FDA Inspection 1078834 - 2019-02-05
- FDA Inspection 1037571 - 2017-11-17
- FDA Inspection 1025918 - 2017-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.